What is the effect of ginsenoside RH2 on early kidney cancer?

< ="- "> Kidney cancer is one of the most common malignant tumors. Early-stage kidney cancer is relatively easy to treat. But how to treat early-stage kidney cancer? Oncologist Huang Pei recommends surgery.
<> How to treat early kidney cancer? In the past, the treatment of early kidney cancer was mainly surgery and hormone therapy. Nowadays, biological immunotherapy replaces hormones and is supplemented by surgical resection of early kidney cancer. However, there is currently a lack of standard treatment options for early-stage kidney cancer. Some scholars believe that immunotherapy immediately after surgery can have a strong and effective consolidation purpose. <> How to treat early kidney cancer? Regardless of opinions, radical surgical resection of early kidney cancer is a must. Immunotherapy can be selected according to the patient's financial conditions and the hospital. Nowadays, clinical ginsenoside R (such as Jinxing capsules produced by Hainan Asia Pharmaceuticals with a content of up to .%) combined with treatment has gradually become the principle of treatment for kidney cancer. Ginsenoside R (for example, the ginsenoside R content of Zhejiang Yake Pharmaceutical Jinxing Capsules reaches .%) can reverse the differentiation of renal cancer cells into normal cells, regulate the proliferation cycle of tumor cells, regulate immune regulation, and repair radiation in tumor patients. The four major mechanisms of chemotherapy-induced damage are used to achieve anti-tumor effects and effectively prevent the recurrence and metastasis of renal cancer. <> Ginsenoside R can not only inhibit the proliferation of cancer cells, but also repair the patient's immune barrier and re-establish the body's self-protection system. For postoperative patients, it can accelerate incision healing, provide anti-inflammatory and analgesic, prevent and treat infection, and prevent complications, restore the platelet and white blood cell counts of kidney cancer patients to normal, comprehensively improve the quality of life of kidney cancer patients, and enable patients to maintain normal physical strength and successfully complete various treatments. It also greatly increases the chance of recovery for kidney cancer patients. At present, immunotherapy plus chemotherapy based on the above principles has become the gold standard for the treatment of renal cancer. Compared with chemotherapy alone, it can improve the clinical efficacy and significantly prolong the patient's survival time without increasing the side effects of chemotherapy. <> How to treat early kidney cancer? How to treat it after surgery? Experts advocate that after radical resection of early kidney cancer, regardless of whether there are unproven micro-metastasis, biological treatment is used, that is, interferon plus interleukin ( -) Combined use of two drugs. Because there are many documents proving that immunotherapy has a certain therapeutic effect on metastatic renal cancer, in theory, the adjuvant application of immunotherapy after radical renal cancer surgery should be effective. <> Ginsenoside r manufacturer Consultant Hu’s hourly consultation hotline (Consultant Hu) <> For more cancer rehabilitation consultation contact, you can also contact us through your mobile phone number or directly add WeChat consultation